Primary angioplasty in acute myocardial infarction with distal protection of the microcirculation: Principal results from the prospective, randomized EMERALD trial

被引:14
|
作者
Stone, GW
Webb, J
Cox, DA
Brodie, BR
Qureshi, M
Dulas, D
Kalynych, A
Turco, M
Schultheiss, HP
Rutherford, B
Kruckoff, M
Gibbons, R
Lansky, AJ
Pop, R
Mehran, R
Jones, D
机构
[1] Cardiovasc Res Fdn, New York, NY USA
[2] Lenox Hill Heart & Vasc Inst, New York, NY USA
关键词
D O I
10.1016/S0735-1097(04)91210-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:285A / 286A
页数:2
相关论文
共 50 条
  • [31] Angioplasty or Primary Stenting for Infrapopliteal Lesions: Results of a Prospective Randomized Trial
    C. Randon
    B. Jacobs
    F. De Ryck
    F. Vermassen
    CardioVascular and Interventional Radiology, 2010, 33 : 260 - 269
  • [32] Angioplasty or Primary Stenting for Infrapopliteal Lesions: Results of a Prospective Randomized Trial
    Randon, C.
    Jacobs, B.
    De Ryck, F.
    Vermassen, F.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2010, 33 (02) : 260 - 269
  • [33] A PROSPECTIVE RANDOMIZED CLINICAL-TRIAL OF INTRACORONARY STREPTOKINASE VERSUS CORONARY ANGIOPLASTY FOR ACUTE MYOCARDIAL-INFARCTION
    ONEILL, W
    TIMMIS, GC
    BOURDILLON, PD
    LAI, P
    GANGHADARHAN, V
    WALTON, J
    RAMOS, R
    LAUFER, N
    GORDON, S
    SCHORK, MA
    PITT, B
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (13): : 812 - 818
  • [34] Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction
    Henriques, JP
    Zijlstra, F
    Ottervanger, JP
    De Boer, MJ
    Hoorntje, JC
    Suryapranata, H
    Klinieken, I
    CIRCULATION, 2001, 104 (17) : 778 - 778
  • [35] RESULTS OF A PROSPECTIVE RANDOMIZED CLINICAL-TRIAL OF INTRAVENOUS NITROGLYCERIN IN ACUTE MYOCARDIAL-INFARCTION
    FLAHERTY, JT
    BECKER, LC
    WEISFELDT, ML
    WEISS, JL
    GERSTENBLITH, G
    KALLMAN, CH
    BULKLEY, BH
    CIRCULATION, 1980, 62 (04) : 82 - 82
  • [36] Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction
    Henriques, JPS
    Zijlstra, F
    Ottervanger, JP
    de Boer, MJ
    van't Hof, AWJ
    Hoorntje, JCA
    Suryapranata, H
    EUROPEAN HEART JOURNAL, 2002, 23 (14) : 1112 - 1117
  • [37] Myocardial protection by intravenous 5-lipoxygenase inhibitor quercetin administration before primary angioplasty in patients with acute myocardial infarction: Short-term results an open blind randomized trial
    Kozhukhov, Sergey
    Parkhomenko, Alexander
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 226A - 226A
  • [38] RANDOMIZED TRIAL OF DEFERRED ANGIOPLASTY AFTER THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION
    VANDENBRAND, MJ
    BETRIU, A
    BESCOS, LL
    NIJSSEN, K
    PFISTERER, ME
    RENKIN, J
    CUSI, LS
    ZIJLSTRA, F
    SIMOONS, ML
    CORONARY ARTERY DISEASE, 1992, 3 (05) : 393 - 401
  • [39] Stent thrombosis after primary angioplasty for acute myocardial infarction: Insights from the typhoon trial
    Spaulding, Christian
    Beatt, Kevin
    Varenne, Olivier
    Henry, Patrick
    Teiger, Emmanuel
    Slama, Michel
    Carrie, Didier
    Bramucci, Ezio
    Cebrian, Ana
    Dalal, Rita
    Snead, David
    Stoll, Hans-Peter
    Bode, Christoph
    CIRCULATION, 2006, 114 (18) : 452 - 452
  • [40] A PROSPECTIVE, PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF INTRAVENOUS STREPTOKINASE AND ANGIOPLASTY VERSUS LONE ANGIOPLASTY THERAPY OF ACUTE MYOCARDIAL-INFARCTION
    ONEILL, WW
    WEINTRAUB, R
    GRINES, CL
    MEANY, TB
    BRODIE, BR
    FRIEDMAN, HZ
    RAMOS, RG
    GANGADHARAN, V
    LEVIN, RN
    CHOKSI, N
    WESTVEER, DC
    STRZELECKI, M
    TIMMIS, GC
    CIRCULATION, 1992, 86 (06) : 1710 - 1717